Intellia Therapeutics Inc buy Barclays PLC
Start price
07.11.25
/
50%
€8.12
Target price
07.11.26
€12.13
Performance (%)
-5.32%
Price
12.12.25
€7.69
Summary
This prediction is currently active. With a performance of -5.32%, the BUY prediction by Barclays_PLC is trending in the wrong direction. This prediction currently runs until 07.11.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -6.699% | -6.699% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Barclays_PLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) had its price target lowered by analysts at Barclays PLC from $24.00 to $14.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Barclays_PLC for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.82
28.02.25
28.02.25
€25.05
28.02.26
28.02.26
-21.74%
12.12.25
12.12.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.58
08.11.24
08.11.24
€51.38
08.11.25
08.11.25
-41.87%
09.11.25
09.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€36.00
04.08.23
04.08.23
€81.52
04.08.24
04.08.24
-40.22%
05.08.24
05.08.24